News in the Life Sciences Industry

STOCKHOLM, July 10, 2018 /PRNewswire/ -- Access to good biomarkers is crucial in selecting the right patient groups for future clinical trials, thus increasing the likelihood that the study will succeed and, in the long run, allowing the development of effective treatment to combat severe... Read more ››

STOCKHOLM, July 10, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces today the results of the BAN2401 Phase 2b clinical study (ClinicalTrials.gov identifier NCT01767311), will be presented in an oral session at the 2018 Alzheimer's Association International Conference... Read more ››

TAIPEI, Taiwan, July 9, 2018 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC). OBI-3424 is a first in... Read more ››

STOCKHOLM, July 9, 2018 /PRNewswire/ -- During the period 2 July 2018 to 6 July 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 365,224 own shares (ISIN: SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme that... Read more ››

LUND, Sweden, July 9, 2018 /PRNewswire/ -- SenzaGen (Nasdaq First North: SENZA) announces today that the company has submitted the official validation report for GARDpotency(TM) to the relevant regulatory authorities as a complement to the validation of GARDskin(TM). GARDpotency(TM)... Read more ››

STOCKHOLM, July 6, 2018 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced positive topline results from the Phase 2b study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early Alzheimer's disease. The study achieved statistical significance... Read more ››

STOCKHOLM, July 4, 2018 /PRNewswire/ -- Kobe Proton Center in Japan has recently started clinical application of RayStation 7 for treatment. The first patient was treated in March 2018 using the uniform scanning method with a plan created in RayStation.

ST. FLORIAN, Austria, July 3, 2018 /PRNewswire/ -- EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today unveiled the new SmartView(®) NT3 aligner, which is available on the company's industry benchmark GEMINI(®)... Read more ››

STOCKHOLM, July 3, 2018 /PRNewswire/ -- Provision Healthcare, an industry- leading innovator in comprehensive, collaborative cancer solutions, has treated its first patients using RayStation in combination with Provision's newly developed ProNova SC360 proton therapy system.

STOCKHOLM, July 2, 2018 /PRNewswire/ -- During the period 25 June 2018 to 29 June 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 460,816 own shares (ISIN: SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme that... Read more ››

STOCKHOLM, July 2, 2018 /PRNewswire/ -- On 18 July, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) will publish its report for the second quarter 2018.

STOCKHOLM, June 29, 2018 /PRNewswire/ -- As of 29 June 2018, the last trading day of the month, the aggregate number of shares and votes in Karo Pharma AB amounts to 164,332,782. The increase in the number of shares and votes is attributable to the recently completed rights issue of 54,777,594... Read more ››

GÖTHENBURG, June 29, 2018 /PRNewswire/ -- Capio AB will publish the Interim report for January-June 2018 on Friday, July 20 at approximately 08.00 am (CET).

STOCKHOLM, June 26, 2018 /PRNewswire/ --Cantargia AB today announces pre-clinical results from a study combining the antibody CAN04 (nidanilimab) and chemotherapy. In in vivo based models of cancer, CAN04 was safely combined with the tested chemotherapies. The strongest result was obtained... Read more ››